With the eventual goal of finding better GBM-specific protein biomarkers to aid in understanding and treating GBM, we initiated this investigation into cell-surface proliferating cell nuclear antigen (csPCNA), a potential GBM biomarker. The gene discussed is PCNA; the disease is glioblastoma.